Ignite Creation Date:
2024-05-06 @ 3:41 AM
Last Modification Date:
2024-10-26 @ 11:37 AM
Study NCT ID:
NCT02343679
Status:
WITHDRAWN
Last Update Posted:
2017-02-01
First Post:
2014-12-03
Brief Title:
Novartis PhII Ceritinib LDK378 in RR ALK Hem Malignancies
Sponsor:
Anne Beaven MD
Organization:
Duke University
Organization Data
Organization:
Duke University
Class:
OTHER
Study ID:
Pro00056623
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Anne Beaven MD
Lead Sponsor Class:
OTHER
Responsible Party:
Anne Beaven MD
Responsible Party Title:
Assistant Professor of Medicine
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Duke University
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Novartis | INDUSTRY |